73 related articles for article (PubMed ID: 2117483)
41. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells.
Gresser I; Maury C; Kaido T; Bandu MT; Tovey MG; Maunoury MT; Fantuzzi L; Gessani S; Greco G; Belardelli F
Int J Cancer; 1995 Nov; 63(5):726-31. PubMed ID: 7591292
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of mouse interferon alpha/beta compared to single-agent chemotherapy in increasing survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
Gresser I; Maury C; Belardelli F; Maunoury MT; Machover D
J Natl Cancer Inst; 1988 Mar; 80(2):126-31. PubMed ID: 3422696
[TBL] [Abstract][Full Text] [Related]
43. Effects of thymectomy and antithymocyte serum on spontaneous regression of Friend virus-induced erythroleukemia.
Dietz M; Furmanski P; Clymer R; Rich MA
J Natl Cancer Inst; 1976 Jul; 57(1):91-5. PubMed ID: 1087346
[TBL] [Abstract][Full Text] [Related]
44. Influence of immune stimulators on viral leukemogenesis.
Marx PA; Wheelock EF
Ann N Y Acad Sci; 1976; 276():502-12. PubMed ID: 1071975
[TBL] [Abstract][Full Text] [Related]
45. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.
Gresser I; Belardelli F; Tavernier J; Fiers W; Podo F; Federico M; Carpinelli G; Duvillard P; Prade M; Maury C
Int J Cancer; 1986 Nov; 38(5):771-8. PubMed ID: 3464571
[TBL] [Abstract][Full Text] [Related]
46. A murine model system for the study of the human leukemia-associated inhibitory activity.
Marcelletti J; Furmanski P
Blood; 1980 Jul; 56(1):134-7. PubMed ID: 6966947
[TBL] [Abstract][Full Text] [Related]
47. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.
Dvorak HF; Gresser I
J Natl Cancer Inst; 1989 Apr; 81(7):497-502. PubMed ID: 2921774
[TBL] [Abstract][Full Text] [Related]
48. Immunomodulatory agents: the cytokines.
Stein RC; Dalgleish AG
Eur J Cancer; 1994; 30A(3):400-4. PubMed ID: 8204368
[No Abstract] [Full Text] [Related]
49. Therapeutic potential of cytokines: a comparison of preclinical and clinical studies.
Talmadge JE
Prog Exp Tumor Res; 1988; 32():154-73. PubMed ID: 3131832
[No Abstract] [Full Text] [Related]
50. Induction and regression of Friend leukemia in vaccinated mice by means of parabiosis.
Takizawa K; Yamamoto T
Gan; 1970 Dec; 61(6):605-6. PubMed ID: 5499689
[No Abstract] [Full Text] [Related]
51. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
Yoshimura A; Shiku H; Nakayama E
J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
[TBL] [Abstract][Full Text] [Related]
52. Lymphokine-activated killer cell plus recombinant interleukin-2 therapy of erythroleukemia in mice.
Johnson CS; Thurlow SM; Furmanski P
Leukemia; 1989 Feb; 3(2):91-6. PubMed ID: 2783472
[TBL] [Abstract][Full Text] [Related]
53. Genetic resistance to Friend virus-induced erythroleukemia and immunosuppression.
Kumar V; Bennett M
Curr Top Microbiol Immunol; 1981; 92():65-82. PubMed ID: 6458455
[No Abstract] [Full Text] [Related]
54. New therapeutic strategies in the treatment of murine diseases induced by virus and solid tumors: biology and implications for the potential treatment of human leukemia, AIDS, and solid tumors.
Shen RN; Lu L; Broxmeyer HE
Crit Rev Oncol Hematol; 1990; 10(3):253-65. PubMed ID: 2257087
[TBL] [Abstract][Full Text] [Related]
55. Immunotherapeutic approaches to leukemia: the use of the Friend virus-induced erythroleukemia model system.
Johnson CS; Chang MJ; Thurlow SM; Pourbohloul SC; Furmanski P
Cancer Res; 1990 Sep; 50(17 Suppl):5682S-5686S. PubMed ID: 2117483
[TBL] [Abstract][Full Text] [Related]
56. Induction of leukemia regression in mice by immunotherapeutic transfer of T-lymphocytes.
Johnson CS; Thurlow SM; Furmanski P
Cancer Res; 1986 Jan; 46(1):183-9. PubMed ID: 3079585
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
